SYBXSYNLOGIC, INC.

Nasdaq synlogictx.com


$ 1.89 $ -0.04 (-2.19 %)    

Tuesday, 07-May-2024 15:59:54 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 1.79
$ 1.88
$ 1.77 x 100
$ 1.82 x 100
$ 1.86 - $ 1.89
$ 1.55 - $ 9.90
7,123
na
11.64M
$ 0.82
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-19-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-29-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-17-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-13-2021 03-31-2021 10-Q
13 03-25-2021 12-31-2020 10-K
14 11-05-2020 09-30-2020 10-Q
15 08-06-2020 06-30-2020 10-Q
16 05-08-2020 03-31-2020 10-Q
17 03-12-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-08-2019 06-30-2019 10-Q
20 05-09-2019 03-31-2019 10-Q
21 03-12-2019 12-31-2018 10-K
22 11-13-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 03-20-2018 12-31-2017 10-K
26 11-13-2017 09-30-2017 10-Q
27 08-04-2017 06-30-2017 10-Q
28 05-09-2017 03-31-2017 10-Q
29 03-15-2017 12-31-2016 10-K
30 11-10-2016 09-30-2016 10-Q
31 08-15-2016 06-30-2016 10-Q
32 05-12-2016 03-31-2016 10-Q
33 03-30-2016 12-31-2015 10-K
34 11-13-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-upgrades-synlogic-to-neutral

HC Wainwright & Co. analyst Ed Arce upgrades Synlogic (NASDAQ:SYBX) from Sell to Neutral.

 synlogic-q4-eps-171-misses-097-estimate-sales-277m-beat-273m-estimate

Synlogic (NASDAQ:SYBX) reported quarterly losses of $(1.71) per share which missed the analyst consensus estimate of $(0.97) by...

 synlogic-adopts-limited-duration-stockholders-rights-plan-and-authorized-a-dividend-distribution-of-one-right-for-each-outstanding-share-of-common-stock-effective-immediately-and-has-a-1-year-duration-expiring-on-february-20-2025

Synlogic, Inc. (NASDAQ:SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious disease...

 why-synlogic-sybx-stock-is-down-nearly-50-today

Synlogic shares are trading lower by 48.4% to $1.78 Friday afternoon. The company announced it will discontinue Synpheny-3, cea...

 crude-oil-moves-higher-newell-brands-issues-weak-outlook

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 1% on Friday. The Dow trade...

 why-take-two-interactive-software-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter res...

 nasdaq-jumps-over-100-points-pinterest-sales-miss-expectations

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 100 points on Friday. The Dow traded d...

 rare-disease-focused-synlogic-pulls-plug-on-lead-program-shares-nosedive

Synlogic discontinues Synpheny-3 study for PKU treatment. Explore strategic options as CEO Dr. Aoife Brennan departs.

 sp-500-tops-5000-pepsico-posts-upbeat-earnings

U.S. stocks traded mixed this morning, with the S&P 500 topping the 5,000 mark on Friday. Following the market opening Fri...

 why-cloudflare-shares-are-trading-higher-by-over-25-here-are-20-stocks-moving-premarket

Shares of Cloudflare, Inc. (NYSE: NET) rose sharply in today’s pre-market trading after the company reported better-than-expec...

 chardan-capital-downgrades-synlogic-to-neutral

Chardan Capital analyst Keay Nakae downgrades Synlogic (NASDAQ:SYBX) from Buy to Neutral.

 leerink-partners-downgrades-synlogic-to-market-perform-announces-1-price-target

Leerink Partners analyst Joseph Schwartz downgrades Synlogic (NASDAQ:SYBX) from Outperform to Market Perform and announces $...

 hc-wainwright--co-downgrades-synlogic-to-sell

HC Wainwright & Co. analyst Ed Arce downgrades Synlogic (NASDAQ:SYBX) from Buy to Sell.

 synlogic-publishes-preclinical-and-clinical-data-for-synb1353-as-potential-treatment-for-classical-homocystinuria

Findings support positive proof of mechanism, through successful degradation of methionine, precursor to homocysteine, using di...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION